TRV GP V, LLC
CIK 1990717
13F filing for Q2 2026・No. 3,898
- Holdings
- US$498.24M
- Quarter change
- +US$97.24M
- Entries
- 3
- Net bought (estimate)
- −US$35.62M
The quarter change is the holdings' value against the quarter before, price moves included — not what was bought or sold; each institution's page estimates that.
Net bought (estimate)
Each stock's change in shares at the quarter-end price, added up: a new position counts as bought, one sold out as sold, shares held long only. Splits are compared split-adjusted; corporate actions under a new CUSIP are not estimated. An estimate from the filings, not actual trades.
- New 0
- Sold out 0
- Cut 1
- Added 0
- Corporate actions 0
- Unchanged 2
Largest holdings
3 stocks worth US$498.24M, options and bonds left out.
| Stock | This quarter | Shares | Value | Weight |
|---|---|---|---|---|
| RAPPORT THERAPEUTICS, INC.COM | Cut | 6,280,525 | US$261.71M | 52.53% |
| SEPTERNA, INC.COM | Unchanged | 6,215,591 | US$208.16M | 41.78% |
| MAZEMAZE THERAPEUTICS, INC.COM | Unchanged | 950,800 | US$28.37M | 5.69% |
Sign in (free) to see its 3 largest holdings and its trades. Sign in
Filings
The quarter's original 13F filings (SEC).
- 13F-HRFiled August 10, 2026SEC ↗
13F covers long positions in US-listed securities only; the data is SEC's, filed within 45 days of the quarter's end.